Kjellson Nina S
SEC-identified person · CIK 1381980 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sevion Therapeutics, Inc. SVOND | Director | filed 2026 - 2026 |
| Tyra Biosciences, Inc. TYRA | Director | filed 2021 - 2025 |
| Panacea Acquisition Corp. II PANA | Director | filed 2021 - 2021 |
| Tranzyme INC TZYM | Director | filed 2013 - 2017 |
| Eiger Biopharmaceuticals, Inc. EIGR | Director | filed 2016 - 2017 |
| Glaukos Corp GKOS | Officer | filed 2015 - 2015 |
| Invuity, Inc. IVTY | Officer | filed 2015 - 2015 |
| Cidara Therapeutics, Inc. CDTX | Director | filed 2015 - 2015 |
| Kalvista Pharmaceuticals, Inc. KALV | Officer | filed 2015 - 2015 |
| Marketo, Inc. MKTO | Officer | filed 2013 - 2014 |
| Trius Therapeutics Inc TSRX | Director | filed 2010 - 2013 |
| Tesaro, Inc. TSRO | Officer | filed 2012 - 2013 |
| Transcept Pharmaceuticals Inc TSPT | Officer | filed 2011 - 2011 |
| Reshape Weightloss Inc. etrm | Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.